Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors

This study is testing a special imaging scan called a Gallium-68 PET/CT scan to see how well it detects and evaluates neuroendocrine tumors in the digestive system and pancreas. These are slow-growing tumors that can be hard to detect. The scan uses a radioactive tracer that specifically targets these tumor types. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with, or are suspected of having, a neuroendocrine tumor of the gut or pancreas - You are in reasonably good health (able to carry out light activities) - You can lie flat for the duration of the scan **You may NOT be eligible if...** - You are unable to lie still for the scan due to conditions like severe coughing, claustrophobia, or severe arthritis - You are pregnant, planning to become pregnant, or breastfeeding - You have an active infection or unexplained high fever Talk to your doctor to see if this trial is right for you.